S. Brissette

发表

Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial.

M. Schechter, A. Anis, D. Guh, 2016, JAMA psychiatry.

Hydromorphone ComparedWith Diacetylmorphine for Long-termOpioid Dependence A Randomized Clinical Trial

M. Schechter, A. Anis, D. Guh, 2016 .

Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: Rationale and design of the NAOMI study

M. Schechter, A. Anis, D. Guh, 2009, Clinical Trials.

Diacetylmorphine versus methadone for the treatment of opioid addiction.

Martin T Schechter, M. Schechter, A. Anis, 2009, The New England journal of medicine.

Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency

M. Schechter, D. Guh, D. Marsh, 2011, BMC health services research.

Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trial

E. Stip, J. Bruneau, Violaine Mongeau-Pérusse, 2022, Pharmacology Biochemistry and Behavior.

Physician Communication in Injectable Opioid Agonist Treatment: Collecting Patient Ratings With the Communication Assessment Tool

M. Schechter, D. Guh, D. Marsh, 2020, Journal of addiction medicine.

The North American Opiate Medication Initiative (NAOMI): Profile of Participants in North America’s First Trial of Heroin-Assisted Treatment

M. Schechter, A. Anis, B. Nosyk, 2008, Journal of Urban Health.

The quality of eight health status measures were compared for chronic opioid dependence.

M. Schechter, A. Anis, D. Guh, 2010, Journal of clinical epidemiology.

Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment

N. Bansback, M. Schechter, A. Anis, 2012, Canadian Medical Association Journal.

Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder.

M. Schechter, A. Anis, D. Guh, 2017, Drug and alcohol dependence.

Cost‐effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial

N. Bansback, M. Schechter, A. Anis, 2018, Addiction.

Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage.

M. Bilodeau, R. Moirand, J. Bruneau, 2007, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Systematic review of the pharmacological treatment of alcohol use disorders in individuals infected with hepatitis C

D. Jutras-Aswad, S. Brissette, A. Thibault, 2015, Addiction Science & Clinical Practice.

Reduced sensory and motor nerve conduction velocities in moderate drinkers

R. Butterworth, M. D'Amour, S. Brissette, 2000, Addiction biology.

Role of Thiamine Deficiency in the Pathogenesis of Alcoholic Peripheral Neuropathy and the Wernicke-Korsakoff Syndrome: An Update

R. Butterworth, M. D'Amour, S. Brissette, 1991 .

Men’s and women’s response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder

M. Schechter, A. Anis, D. Guh, 2017, Substance Abuse Treatment, Prevention, and Policy.

Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial.

J. Bruneau, D. Jutras-Aswad, B. Foll, 2022, Drug and alcohol dependence.

History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment.

M. Schechter, A. Anis, D. Guh, 2011, Addictive behaviors.

Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial.

T. Wild, B. Le Foll, J. Bruneau, 2022, The American journal of psychiatry.

Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment

M. Schechter, D. Guh, D. Marsh, 2012, Harm Reduction Journal.

Predictors of non-use of illicit heroin in opioid injection maintenance treatment of long-term heroin dependence.

M. Schechter, A. Anis, D. Guh, 2015, Addictive Behaviours.

ANALYSIS & COMMENTARY A Call For Evidence-Based Medical Treatment Of Opioid Dependence In The United States And Canada

B. Schackman, M. Anglin, E. Wood, 2013 .

Medical prescription of heroin--a review.

S. Brissette, 2001, Canadian HIV/AIDS policy & law review.

Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods.

M. Schechter, A. Anis, D. Guh, 2019, Journal of substance abuse treatment.

Adverse Events During Treatment Induction With Injectable Diacetylmorphine and Hydromorphone for Opioid Use Disorder

M. Schechter, A. Anis, D. Guh, 2019, Journal of addiction medicine.

A call for evidence-based medical treatment of opioid dependence in the United States and Canada.

J. Montaner, B. Schackman, M. Anglin, 2013, Health affairs.

Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo‐controlled trial

E. Stip, P. Conrod, J. Bruneau, 2021, Addiction.

Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users.

J. Rehm, F. Leri, N. el-Guebaly, 2007, Drug and alcohol dependence.

Estimating the size of the population of persons who inject drugs in the island of Montréal, Canada, using a six-source capture-recapture model.

A. Vandal, C. Archibald, J. Bruneau, 2014, Drug and alcohol dependence.

Determinants of overdose incidents among illicit opioid users in 5 Canadian cities

J. Rehm, N. el-Guebaly, S. Brochu, 2004, Canadian Medical Association Journal.

Illicit opioid use in Canada: Comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study)

J. Rehm, N. el-Guebaly, S. Brochu, 2005, Journal of Urban Health.

Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women.

M. Schechter, A. Anis, D. Guh, 2010, Drug and alcohol dependence.

he effect of motivational status on treatment outcome in the North American piate Medication Initiative ( NAOMI ) study

M. Schechter, J. Geller, A. Anis, 2010 .

Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.

M. Schechter, A. Anis, D. Guh, 2010, Journal of substance abuse treatment.

Characteristics and Response to Treatment among Aboriginal People Receiving Heroin-assisted Treatment

M. Schechter, A. Anis, D. Guh, 2010 .

Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial

E. Stip, J. Cailhier, J. Bruneau, 2021, Neuropsychopharmacology.

History of Treatment Access and Drug Use among Participants in a Trial Testing Injectable Opioids under Supervision for Long-Term Heroin Injectors

M. Schechter, A. Anis, D. Guh, 2015 .

Characteristics and response to treatment among Aboriginal people receiving heroin-assisted treatment.

M. Schechter, A. Anis, D. Guh, 2010, Canadian journal of public health = Revue canadienne de sante publique.

Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long‐term opioid dependence

M. Schechter, A. Anis, D. Guh, 2018, Drug and alcohol review.

Longitudinal patterns of cocaine use among patients receiving injectable hydromorphone or diacetylmorphine for the treatment of opioid use disorder: A growth curve modeling approach.

M. Schechter, D. Guh, D. Marsh, 2020, Drug and alcohol dependence.

Predictors of treatment allocation guesses in a randomized controlled trial testing double-blind injectable hydromorphone and diacetylmorphine for severe opioid use disorder

M. Schechter, A. Anis, D. Guh, 2017 .

Comorbid Depression among Untreated Illicit Opiate Users: Results from a Multisite Canadian Study

J. Rehm, N. el-Guebaly, T. Wild, 2005, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA study.

J. Rehm, E. Wood, B. Le Foll, 2023, Journal of substance use and addiction treatment.

Health and Social Services Accessed by a Cohort of Canadian Illicit Opioid Users Outside of Treatment

J. Rehm, N. el-Guebaly, T. Wild, 2006, Canadian journal of public health = Revue canadienne de sante publique.

The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder

M. Schechter, A. Anis, D. Guh, 2018, Addictive behaviors reports.

M. Schechter, A. Anis, D. Guh, 2011, Drug and alcohol dependence.

Patterns of opioid and cocaine co-use: a descriptive study in a Canadian sample of untreated opioid-dependent individuals.

F. Leri, N. el-Guebaly, T. Wild, 2005, Experimental and clinical psychopharmacology.

Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial

B. Le Foll, D. Jutras-Aswad, M. Socías, 2022, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

A chance to stop and breathe: participants’ experiences in the North American Opiate Medication Initiative clinical trial

M. Schechter, A. Anis, J. Chettiar, 2014, Addiction Science & Clinical Practice.

A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance use research.

M. Schechter, D. Guh, D. Marsh, 2021, Journal of substance abuse treatment.

A pilot, open-label, 8-week study evaluating desvenlafaxine for treatment of major depression in methadone-maintained individuals with opioid use disorder

F. Lespérance, J. Bruneau, P. Lespérance, 2018, International clinical psychopharmacology.

Understanding Steps and Challenges to Take-home Naloxone and Buprenorphine/naloxone Implementation in Québec Emergency Rooms: Suboxed Project

C. Ouellette, S. Brissette, P. Lauzon, 2020 .

Differential long-term outcomes for voluntary and involuntary transition from injection to oral opioid maintenance treatment

M. Schechter, A. Anis, D. Guh, 2014, Substance Abuse Treatment, Prevention, and Policy.

Diacetylmorphine versus methadone for the treatment of opioid addiction.

M. Schechter, A. Anis, D. Guh, 2009, The New England journal of medicine.

Estimating the size of the population of persons who inject drugs in the island of Montréal, Canada, using a six-source capture-recapture model.

A. Vandal, C. Archibald, J. Bruneau, 2014, Drug and alcohol dependence.

Sexual activity and sleep in humans

R. Godbout, J. Montplaisir, S. Brissette, 1985, Biological Psychiatry.

M. Schechter, A. Anis, D. Guh, 2011, Drug and alcohol dependence.

The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study.

A. Anis, D. Guh, E. Oviedo-Joekes, 2010, Drug and alcohol dependence.

Potency ratio of hydromorphone and diacetylmorphine in substitution treatment for long-term opioid dependency.

M. Schechter, D. Guh, D. Marsh, 2011, Journal of opioid management.